For research use only. Not for therapeutic Use.
BLM-IN-1(Cat No.:I019395)is a small molecule inhibitor that targets the Bloom syndrome protein (BLM), a DNA helicase involved in DNA repair and genomic stability. By inhibiting BLM, BLM-IN-1 can prevent the growth and proliferation of cancer cells that depend on BLM for survival. Preclinical studies have shown that BLM-IN-1 is effective against a variety of cancer types, making it a promising candidate for further development as an anticancer therapy.
Catalog Number | I019395 |
CAS Number | 2056014-40-3 |
Molecular Formula | C₂₈H₃₅FN₄O |
Purity | ≥95% |
Target | Apoptosis |
Storage | Store at -20°C |
IUPAC Name | (3E)-6-[3-(diethylamino)propylamino]-7-fluoro-3-[(4-propan-2-ylphenyl)methylidene]-1,2-dihydropyrrolo[2,1-b]quinazolin-9-one |
InChI | InChI=1S/C28H35FN4O/c1-5-32(6-2)14-7-13-30-26-18-25-23(17-24(26)29)28(34)33-15-12-22(27(33)31-25)16-20-8-10-21(11-9-20)19(3)4/h8-11,16-19,30H,5-7,12-15H2,1-4H3/b22-16+ |
InChIKey | GZSNGNPLURZQGM-CJLVFECKSA-N |
SMILES | CCN(CC)CCCNC1=C(C=C2C(=C1)N=C3C(=CC4=CC=C(C=C4)C(C)C)CCN3C2=O)F |
Reference | [1]. Yin QK, et al. Discovery of Isaindigotone Derivatives as Novel Bloom’s Syndrome Protein (BLM) Helicase Inhibitors That Disrupt the BLM/DNA Interactions and Regulate the Homologous Recombination Repair. J Med Chem. 2019 Mar 28;62(6):3147-3162. |